New methods for RWE collection and synthesis

Welcome to GetReal

Objectives

The ultimate goal of the GetReal Initiative is to drive the sustainable adoption of tools, methodologies and best practices from IMI GetReal and thereby increase the quality of real-world evidence (RWE) generation in drug development and regulatory/Health Technology Assessment (HTA) processes across Europe. In this way, the project is committed to maximizing the societal value of public and private investments in the IMI GetReal project.These goals will be achieved through:

- 1 -

Optimising and ensuring the adoption and sustainability of the tools and frameworks (developed under GetReal) which help make better-informed decisions on (i) the possible role of RWE in drug development and healthcare decision making, (ii) pragmatic trial design choices and their consequences and (iii) improve the efficiency, transparency and shareability of network- and benefit-risk analyses.
 

- 2 -

The creation of a leading, task orientated, RWE research community, building on the recognition and trust conveyed by the GetReal name, to enable interaction and partnership on science and innovation in RWE involving, patients, regulators, HTA bodies, academia and companies.

 

 

- 3 -

The establishment of a small self sustaining unit, run on a not-for-profit basis, to ensure that beyond the term of this project (i) the tools, knowledge and educational materials generated in GetReal remain available to the broader scientific community; (ii) the Think Tank, Task Forces and RWE Research Community are maintained and thus anchoring the GetReal Initiative as an internationally renowned body for leading innovation in evidence generation and healthcare decision making.

                                                 

The research leading to these results has received support from the EU/EFPIA Innovative Medicines Initiative [2] Joint Undertaking GetReal Initiative grant n°807012.